Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 219 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| BCAM | ENSG00000187244 | 0.00 | 0.29 | 0 | 1 |
| IL2RA | ENSG00000134460 | 0.19 | 0.00 | 1 | 0 |
| LBP | ENSG00000129988 | 0.00 | 0.00 | 0 | 0 |
| HSD17B12 | ENSG00000149084 | 0.16 | 0.00 | 1 | 0 |
| SIK2 | ENSG00000170145 | 0.00 | 1.08 | 0 | 6 |
| THSD4 | ENSG00000187720 | 0.00 | 0.00 | 0 | 0 |
| SCN9A | ENSG00000169432 | 0.00 | 0.00 | 0 | 0 |
| COL4A2 | ENSG00000134871 | 0.16 | 0.00 | 1 | 0 |
| SLC15A4 | ENSG00000139370 | 0.00 | 0.27 | 0 | 2 |
| AOAH | ENSG00000136250 | 0.00 | 0.00 | 0 | 0 |
| KLK7 | ENSG00000169035 | 0.00 | 0.00 | 0 | 0 |
| PAMR1 | ENSG00000149090 | 0.00 | 0.00 | 0 | 0 |
| TNC | ENSG00000041982 | 0.00 | 0.00 | 0 | 0 |
| DUSP26 | ENSG00000133878 | 0.00 | 0.00 | 0 | 0 |
| CAPZA2 | ENSG00000198898 | 0.62 | 0.00 | 4 | 0 |
| IRAK1 | ENSG00000184216 | 1.02 | 0.00 | 6 | 0 |
| CSPG4 | ENSG00000173546 | 0.00 | 0.00 | 0 | 0 |
| LINGO2 | ENSG00000174482 | 0.00 | 0.00 | 0 | 0 |
| ERBB4 | ENSG00000178568 | 0.00 | 0.00 | 0 | 0 |
| CBR3 | ENSG00000159231 | 0.10 | 0.00 | 1 | 0 |
|
Showing page 219 |
first page | previous page | next page | last page |